TerminatedNCT01310140
Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
Observational studyAges 18–85United StatesDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 85 years.
- Listed locations
- BostonSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 2011
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 14
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- United States
- Age range
- From 18 Years to 85 Years
- Official registry ID
- NCT01310140
- Official title
Show the full official title
Comparative Risks for Insulin Resistance and Metabolic Syndrome (MS) Among Hospitalized Patients With Major Depressive Disorder With (MDpsy) or Without (MDD) Psychotic Features
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Who can participate?
Listed age limits: 18 years to 85 years.
Is this study still recruiting?
The registry lists this study as terminated.
